TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" saw a 5.77% return in Q1 2024, outperforming the Russell 2000 Growth Index. Highlighting Krystal Biotech, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" saw a 5.77% return in Q1 2024, outperforming the Russell 2000 Growth Index. Highlighting Krystal Biotech, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.